Cargando...
Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities
Nimotuzumab is a humanized monoclonal antibody that binds specifically to human epidermal growth factor receptor, blocking receptor activation. Evidence of its radiosensitizing capacity has been widely evaluated. This article integrates published research findings regarding the role of nimotuzumab i...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3729249/ https://ncbi.nlm.nih.gov/pubmed/23926436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S33532 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|